|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/337 | |
| A61K 31/416 | |||
| A61K 31/513 | |||
| A61K 31/517 | |||
| A61K 31/5355 | |||
| A61K 31/555 | |||
| A61K 39/395 | |||
| A61K 45/06 | |||
| A61P 35/00 | |||
| G01N 33/574 | |||
| A61K 47/48 | |||
| A61K 31/5377 |
| (11) | Patento numeris | 2254571 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09721522.2 |
| Europos patento paraiškos padavimo data | 2009-03-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-12-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-07-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2009/036608 |
| Data | 2009-03-10 |
| (87) | Numeris | WO 2009/117277 |
| Data | 2009-09-24 |
| (30) | Numeris | Data | Šalis |
| 37410 P | 2008-03-18 | US |
| (72) |
BERRY, Leanne, US
PHILLIPS, Gail, Lewis, US
SLIWKOWSKI, Mark, X., US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080,
US
|
| (54) | COMBINATIONS OF AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND CHEMOTHERAPEUTIC AGENTS, AND METHODS OF USE |
| COMBINATIONS OF AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND CHEMOTHERAPEUTIC AGENTS, AND METHODS OF USE |